<DOC>
	<DOCNO>NCT00346502</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness experimental 20 % betulinic acid ointment ( BA ointment ) treatment dysplastic nevi potential transform melanoma .</brief_summary>
	<brief_title>Evaluation 20 % Betulinic Acid Ointment Treatment Dysplastic Nevi ( Moderate Severe Dysplasia )</brief_title>
	<detailed_description>Approximately 200 patient may enrol screened order find twenty-eight ( 28 ) patient qualify involve research UIC . Dysplastic melanocytic nevus ( DMN ) histopathologic term imply disorder proliferation melanocyte associate discontinuous variable cellular atypia . DMN grade mild , moderate , severe base standard histological criterion . DMN consider likely precursor melanoma , individual DMN often multiple instance scatter trunk extremity . For study , DMN dysplasia either moderate severe include .</detailed_description>
	<mesh_term>Nevus</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Dysplastic Nevus Syndrome</mesh_term>
	<mesh_term>Betulinic acid</mesh_term>
	<criteria>All race eligible entry Study . All patient must histologically document ( punch biopsy ) dysplastic nevus moderate severe dysplasia ( DMN ) . A similar biopsy proven DMN serve control need available . Patients must healthy active normal pursuit life able provide inform write consent . Localized dermatological condition like psoriasis actinic keratosis exclusion criterion . Patients must ambulatory ECOG status &lt; 2 ; hospitalize part Study . All patient study , addition normal clinical examination , thorough skin examination . Whenever possible , periodic photograph lesion take . Additional test patient within 30 day initiation topical application include urinalysis , liver function test ( LFT ) , blood test complete blood count ( CBC ) , BUN , creatinine . Women pregnant and/or nursing exclude . A pregnancy test perform premenopausal woman within two day entry Study , negative pregnancy test must record case report form prior initiate use topical application . Patients treat chronic debilitating disease ( cardiac , pulmonary , organ specific disease ) . Immunosuppressed patient , either due chemotherapy radiation therapy know immunodeficiency disease ( e.g. , AIDS ) . Patients active malignancy within past five year , exclude noninvasive skin cervical carcinoma . Patients serious medical psychiatric illness would prevent informed consent . Patients extensive chronic skin disease extensive psoriasis , atopic dermatitis , xeroderma pigmentosa exclude Study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>